Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria

Detalles Bibliográficos
Autores principales: To, Fergus, Parker, Matthew J. S., Ventín-Rodríguez, Clara, Lilleker, James B., Chinoy, Hector
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880850/
https://www.ncbi.nlm.nih.gov/pubmed/31382296
http://dx.doi.org/10.1093/rheumatology/kez253
_version_ 1783473839938732032
author To, Fergus
Parker, Matthew J. S.
Ventín-Rodríguez, Clara
Lilleker, James B.
Chinoy, Hector
author_facet To, Fergus
Parker, Matthew J. S.
Ventín-Rodríguez, Clara
Lilleker, James B.
Chinoy, Hector
author_sort To, Fergus
collection PubMed
description
format Online
Article
Text
id pubmed-6880850
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68808502019-12-03 Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria To, Fergus Parker, Matthew J. S. Ventín-Rodríguez, Clara Lilleker, James B. Chinoy, Hector Rheumatology (Oxford) Letters to the Editor Oxford University Press 2019-12 2019-06-25 /pmc/articles/PMC6880850/ /pubmed/31382296 http://dx.doi.org/10.1093/rheumatology/kez253 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
To, Fergus
Parker, Matthew J. S.
Ventín-Rodríguez, Clara
Lilleker, James B.
Chinoy, Hector
Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
title Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
title_full Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
title_fullStr Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
title_full_unstemmed Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
title_short Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
title_sort including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880850/
https://www.ncbi.nlm.nih.gov/pubmed/31382296
http://dx.doi.org/10.1093/rheumatology/kez253
work_keys_str_mv AT tofergus includingmyositisspecificautoantibodiesimprovesperformanceoftheidiopathicinflammatorymyopathiesclassificationcriteria
AT parkermatthewjs includingmyositisspecificautoantibodiesimprovesperformanceoftheidiopathicinflammatorymyopathiesclassificationcriteria
AT ventinrodriguezclara includingmyositisspecificautoantibodiesimprovesperformanceoftheidiopathicinflammatorymyopathiesclassificationcriteria
AT lillekerjamesb includingmyositisspecificautoantibodiesimprovesperformanceoftheidiopathicinflammatorymyopathiesclassificationcriteria
AT chinoyhector includingmyositisspecificautoantibodiesimprovesperformanceoftheidiopathicinflammatorymyopathiesclassificationcriteria

Ejemplares similares